Kathleen Mazor to Cluster Analysis
This is a "connection" page, showing publications Kathleen Mazor has written about Cluster Analysis.
Connection Strength
0.399
-
Tai-Seale M, Cheung M, Vaida F, Ruo B, Walker A, Rosen RL, Hogarth M, Fisher KA, Singh S, Yood RA, Garber L, Saphirak C, Li M, Chan AS, Yu EE, Kallenberg G, Longhurst CA, Millen M, Stults CD, Mazor KM. Patient-Clinician Communication Interventions Across Multiple Primary Care Sites: A Cluster Randomized Clinical Trial. JAMA Health Forum. 2024 Dec 06; 5(12):e244436.
Score: 0.222
-
Mazor KM, Sabin JE, Goff SL, Smith DH, Rolnick S, Roblin D, Raebel MA, Herrinton LJ, Gurwitz JH, Boudreau D, Meterko V, Dodd KS, Platt R. Cluster randomized trials to study the comparative effectiveness of therapeutics: stakeholders' concerns and recommendations. Pharmacoepidemiol Drug Saf. 2009 Jul; 18(7):554-61.
Score: 0.076
-
Sabin JE, Mazor K, Meterko V, Goff SL, Platt R. Comparing drug effectiveness at health plans: the ethics of cluster randomized trials. Hastings Cent Rep. 2008 Sep-Oct; 38(5):39-48.
Score: 0.072
-
Pimentel CB, Donovan JL, Field TS, Gurwitz JH, Harrold LR, Kanaan AO, Lemay CA, Mazor KM, Tjia J, Briesacher BA. Use of atypical antipsychotics in nursing homes and pharmaceutical marketing. J Am Geriatr Soc. 2015 Feb; 63(2):297-301.
Score: 0.028